NTV Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

NTV Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5M	Buy	248,500 +59,909	+32%	+$1.91M	1.02%	21
2026 Q1	$4.98M	Buy	188,591 +3,035	+2%	+$88.9K	0.55%	51
2025 Q4	$5.38M	Buy	185,556 +25,360	+16%	+$761K	0.57%	47
2025 Q3	$4.45M	Buy	+160,196	New	+$4.05M	0.49%	60

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

NTV Asset Management's ARKG Position: Q2 2026 in Review

NTV Asset Management increased its ARK Genomic Revolution ETF (ARKG) stake by 32% in Q2 2026, buying an estimated $1.91M and bringing the position to 248,500 shares worth $10.5M. The position accounts for 1.02% of the portfolio, ranked #21.

NTV Asset Management first reported a position in ARKG in Q3 2025 and has held it in 4 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

NTV Asset Management held 248,500 shares of ARK Genomic Revolution ETF worth $10.5M as of Q2 2026.
NTV Asset Management bought 59,909 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.91M.
ARK Genomic Revolution ETF made up 1.02% of NTV Asset Management's portfolio in Q2 2026, its #21 holding.
NTV Asset Management first reported a position in ARK Genomic Revolution ETF in Q3 2025 and has held it in 4 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on NTV Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.